Miniatura

Fitxers

667257.pdf (1.24 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2016-11-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/112026

Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1172/JCI83185

Resum

Huntington's disease (HD) is a polyglutamine disorder caused by a CAG expansion in the Huntingtin (HTT) gene exon 1. This expansion encodes a mutant protein whose abnormal function is traditionally associated with HD pathogenesis; however, recent evidence has also linked HD pathogenesis to RNA stable hairpins formed by the mutant HTT expansion. Here, we have shown that a locked nucleic acid-modified antisense oligonucleotide complementary to the CAG repeat (LNA-CTG) preferentially binds to mutant HTT without affecting HTT mRNA or protein levels. LNA-CTGs produced rapid and sustained improvement of motor deficits in an R6/2 mouse HD model that was paralleled by persistent binding of LNA-CTG to the expanded HTT exon 1 transgene. Motor improvement was accompanied by a pronounced recovery in the levels of several striatal neuronal markers severely impaired in R6/2 mice. Furthermore, in R6/2 mice, LNA-CTG blocked several pathogenic mechanisms caused by expanded CAG RNA, including small RNA toxicity and decreased Rn45s expression levels. These results suggest that LNA-CTGs promote neuroprotection by blocking the detrimental activity of CAG repeats within HTT mRNA. The present data emphasize the relevance of expanded CAG RNA to HD pathogenesis, indicate that inhibition of HTT expression is not required to reverse motor deficits, and further suggest a therapeutic potential for LNA-CTG in polyglutamine disorders.

Matèries

Corea de Huntington, Malalties neurodegeneratives, RNA

Matèries (anglès)

Huntington's chorea, Neurodegenerative Diseases, RNA

Citació

Col·leccions

Articles publicats en revistes (Biomedicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

RUÉ CABRÉ, Laura, BAÑEZ-CORONEL, Mónica, CREUS MUNCUNILL, Jordi, GIRALT TORROELLA, Albert, ALCALÁ VIDA, Rafael, MENTXAKA, Gartze, KAGERBAUER, Birgit, ZOMEÑO ABELLÁN, M. teresa, ARANDA, Zeus, VENTURI, Verónica, PÉREZ NAVARRO, Esther, ESTIVILL, Xavier, MARTÍ PUIG, Eulàlia. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels. _Journal of Clinical Investigation_. 2016. Vol. 126, núm. 11, pàgs. 4319-4330. [consulta: 20 de gener de 2026]. ISSN: 0021-9738. [Disponible a: https://hdl.handle.net/2445/112026]

Exportar metadades

JSON - METS

Compartir registre